[Culture and metagenomics as bacterial identification methods in patients with diabetic foot ulcers: a systematic review]
- PMID: 38293856
- DOI: 10.4067/s0034-98872023000200206
[Culture and metagenomics as bacterial identification methods in patients with diabetic foot ulcers: a systematic review]
Abstract
Background: Diabetic foot osteomyelitis (DFO) is a serious complication of infected ulcers in a diabetic patient. The identification of the infecting microorganisms is generally by culture, which causes a bias. Recently, metagenomics has been used for microbial identification.
Aim: To systematically review the scientific literature related to DFO in the last 10 years to evaluate if culture and metagenomics are complementary.
Material and methods: To carry out the systematic review, PRISMA and Rayyan were used for the selection of studies, using three databases, using the keywords diabetes, osteomyelitis, culture and microbiome. Articles in English or Spanish were included, containing information related to bacterial identification in DFO. Characteristics of the technique, patients and frequency of bacterial appearance were collected.
Results: Twenty six articles were included, 19 used culture and 7 metagenomics. The patients were predominantly men (68%), with an average age of 61 years, 83% had type 2 diabetes and comorbidities, mainly vascular and neuropathy. The Families with the highest frequency of appearance using the culture technique were Enterobacteriaceae (29.3%) and Staphylococcaceae(28.3%) and with metagenomics Peptoniphilaceae (22.1%) and Staphylococcaceae (9.4%). Peptoniphilaceae were not identified in culture, although they were frequently identified by metagenomics. Methicillin- resistant Staphylococcus aureus, regularly identified by culture, was not identified using metagenomics.
Conclusions: Comparing results, there is a certain complementarity between microbiological culture and sequencing to identify bacteria present in DFO.
Similar articles
-
The effectiveness of systemic antibiotics for osteomyelitis of the foot in adults with diabetes mellitus: a systematic review protocol.J Foot Ankle Res. 2022 Jun 17;15(1):48. doi: 10.1186/s13047-022-00554-3. J Foot Ankle Res. 2022. PMID: 35710432 Free PMC article.
-
Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration.JAMA Netw Open. 2019 Nov 1;2(11):e1916003. doi: 10.1001/jamanetworkopen.2019.16003. JAMA Netw Open. 2019. PMID: 31755948 Free PMC article.
-
The increasing prevalence of Enterobacteriaceae as pathogens of diabetic foot osteomyelitis: A multicentre European cohort over two decades.Int J Infect Dis. 2025 May;154:107843. doi: 10.1016/j.ijid.2025.107843. Epub 2025 Feb 13. Int J Infect Dis. 2025. PMID: 39955046
-
Diagnostic and therapeutic update on diabetic foot osteomyelitis.Endocrinol Diabetes Nutr. 2017 Feb;64(2):100-108. doi: 10.1016/j.endinu.2016.10.008. Epub 2017 Feb 10. Endocrinol Diabetes Nutr. 2017. PMID: 28440774 Review. English, Spanish.
-
Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches.Expert Rev Anti Infect Ther. 2018 Jan;16(1):35-50. doi: 10.1080/14787210.2018.1417037. Epub 2017 Dec 19. Expert Rev Anti Infect Ther. 2018. PMID: 29231774 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical